BeaconEquity.com announces the publication of an article covering Cardima receiving CE Mark approval for its Cardima Surgical Ablation System, and the reduced risk associated with ablation of left and right atria.
Investors can view all of the investment articles for free by visiting: http://www.beaconequity.com/m
In the article the author writes:
“Cardima Inc. (OTCBB: CADM), maker of medical devices for the heart and treatment of artial fibrillation, recently announced it has received CE Mark approval for its Surgical Ablation Probe with Stabilization Sheath, with all components of the device now approved for sale in the European market. Cardiac surgeons are now given the option of using the Surgical Ablation Probe in open-chest and closed surgery in treatment of the atria.”
The Cardima Surgical Ablation System reduces risk, shortens recovery time and patient discomfort:
“The company states that the Cardima Surgical Ablation System reduces the risk associated with ablation of left and right atria, and is most likely to shorten recovery time and reduce patient discomfort after the procedure, thus reducing hospital inpatient days to one night in many cases.”
To read the entire article visit http://www.beaconequity.com/m
Join the fastest growing investor community at: http://www.stockhideout.com/
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas.
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. BeaconEquity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
